lovastatin / Generic mfg.  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lovastatin / Generic mfg.
SynCoRAS, NCT03504501 / 2016-005022-10: Synaptic Plasticity and Cognitive Function in RASopathies

Terminated
2
16
Europe
Lovastatin, Lamotrigine
Technical University of Munich
Impaired Synaptic Plasticity, Impaired Cognition
02/23
10/23
NCT02964884: Interventions for Reading Disabilities in NF1

Recruiting
2
120
US
Lovastatin, reading tutoring intervention, Placebo Oral Tablet, Other Academic "sham" tutoring
Vanderbilt University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Neurofibromatosis Type 1, Learning Disability, Reading Disability, NF1
05/26
07/26
NCT04297033: Lovastatin for Treatment of Brain Arteriovenous Malformations

Not yet recruiting
2
1244
RoW
Lovastatin, Placebo
Beijing Tiantan Hospital
Cerebral Arteriovenous Malformation
06/24
06/24

Download Options